✨ Free AI Report
Castle Biosciences Inc: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview Castle Biosciences Inc
Research Preview

Castle Biosciences Inc: Business Overview, Financials & Competitive Analysis

Castle Biosciences is a molecular diagnostics company that provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus, atopic dermatitis, and uveal melanoma. The company lever...

Analyst-debate audio for Castle Biosciences Inc

AskCyborg analysts argue the bull and bear cases for Castle Biosciences Inc across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Castle Biosciences Inc OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
8/ 10Strong

Cyborg Score thesis

High-growth molecular diagnostics company with expanding test portfolio, strong clinical validation, and demonstrated ability to...

Read the full analyst-debate transcript →
Industry In-Vitro Diagnostics
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 5, 2026
AI-Verified Research
30+ Page Report

Get the Latest Castle Biosciences Inc Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Castle Biosciences Inc Overview

Pro stress-test →

Castle Biosciences is a molecular diagnostics company that provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus, atopic dermatitis, and uveal melanoma. The company leverages gene expression profiling and spatialomics technologies to deliver personalized, clinically actionable molecular tests that guide treatment decisions for patients and clinicians.

Strategic Profile

Pro stress-test →

In 2025, Castle achieved total test reports for core revenue drivers (DecisionDx-Melanoma and TissueCypher) increasing 37% over 2024, and exceeded full-year revenue guidance at $344 million. The company maintains strong analyst sentiment with an average "Strong Buy" rating and a 12-month stock price target of $47.17, representing an 84.55% upside from current levels.

Competitive Landscape

Pro stress-test →

Castle competes in the precision oncology diagnostics and molecular testing space against companies like Guardant Health (liquid biopsies for cancer), Myriad Genetics (genetic testing and oncology diagnostics), and Exact Sciences (cancer screening and diagnostics). Castle's differentiation lies in its focus on solid tumor risk stratification, spatialomics technology (TissueCypher), and expansion into adjacent high-value clinical areas like Barrett's esophagus management.

Industry Context

Castle Biosciences Inc operates in In-Vitro Diagnostics.

Key facts

Founded: 2007 · Headquarters: Friendswood, Texas, US · Employees: 761 · Revenue: $344M (2025) · Market cap: $879.2M

What the analysts stress-tested

The top findings that survived the multi-agent debate for Castle Biosciences Inc.

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Castle Biosciences Inc has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Guardant360Liquid biopsy platform for cancer detection and monitoring→MyRiskGenetic testing and cancer risk assessment→Oncotype DXGenomic cancer diagnostics and treatment planning→

Compare Castle Biosciences Inc with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Castle Biosciences Inc operates in In-Vitro Diagnostics. See how the rest of the sector scores on the Cyborg framework.

Browse In-Vitro Diagnostics research →
NEW · MCP server

Ask your AI assistant about Castle Biosciences Inc

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Castle Biosciences Inc and its top competitor on Cyborg Score”
“What did Castle Biosciences Inc do this quarter?”
“Is Castle Biosciences Inc a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Castle Biosciences Inc do?+
Castle Biosciences is a molecular diagnostics company that provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus, atopic dermatitis, and uveal melanoma. The company lever...
What is Castle Biosciences Inc's Cyborg Score?+
Castle Biosciences Inc has a Cyborg Score of 8/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Castle Biosciences Inc's main competitors?+
Named competitors include Guardant360, MyRisk, Oncotype DX. The full competitive landscape is in the AskCyborg report.
How can I get the full Castle Biosciences Inc research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Castle Biosciences Inc research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Castle Biosciences Inc over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More In-Vitro Diagnostics research

Companies in the same sector and named competitors, ranked by Cyborg Score.

7DiaSorin S.p.A.7Shenzhen New Industries Biomedical Engineering Co., Ltd.4Biosynex SA